BioNucleiArchitectureResearch structure

The research architecture of BioNuclei.

BioNuclei is organized as an inspectable chain from data and model computation through cross-domain evaluation, robustness analysis and retained evidence. This page describes that research structure rather than the separate MCP ecosystem.

BioNuclei research structure

Four connected parts of the scientific programme.

Each part has a defined role in the evidence chain. The architecture is a way to organize the research, not a substitute for experimental evidence.

01

Data

Versioned dataset inventories, provenance, split definitions, integrity checks and explicit source, target and independent-validation roles.

02

Segmentation model

The scientific model is evaluated as part of a controlled pipeline, with configuration and execution records retained alongside results.

03

Robustness evaluation

Cross-domain transfer, failure analysis, controlled robustness experiments and prespecified statistical evaluation test what changes when the image domain changes.

04

Evidence and provenance

Artifacts, metrics, configurations, manifests and verification records provide the traceability needed to inspect each scientific claim.

Capability structure

From raw inputs to an inspectable result.

The research pipeline can be read as explicit stages, with each handoff preserving the information required for reproducibility and audit.

01

Dataset inventory

Record declared images, labels, versions and acquisition provenance.

02

Split discipline

Keep source training, target evaluation and independent validation roles explicit.

03

Model execution

Run the declared segmentation configuration without silently changing the protocol.

04

Domain evaluation

Measure transfer behavior on declared evaluation populations.

05

Failure analysis

Characterize where robustness breaks rather than reporting only aggregate performance.

06

Evidence record

Preserve metrics, parameters, artifacts and verification records for inspection.

Scientific boundary

Computation stays with the scientific pipeline.

BioNuclei's research architecture separates the scientific experiment from future interoperability layers. Models and scientific software perform the analysis; later MCP components may provide interfaces around established capabilities.

Inside BioNuclei

Scientific computation

Dataset handling, segmentation, evaluation, robustness analysis, statistics and evidence generation belong to the research programme.

Separate future layer

MCP interoperability

BioMCP and related MCP directions are separate future interfaces for coordinating established scientific capabilities. They are not the scientific foundation of BioNuclei.

Status

BioNuclei is the scientific programme. MCPs are a separate direction.

The website keeps the boundary explicit: datasets, research and scientific architecture belong to BioNuclei; BioMCP, BioFM, BioWF and BioSkills are presented separately as future interoperability and ecosystem directions.